1 item found

Licenses: License Not Specified Tags: 110309 Infectious Diseases Cancer Cell Biology Science Policy Types: other Groups: Metadata-only Access Organisations: RISIS2OpenData

Filter Results
  • other

    Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pre...

    Abstract Background Ipilimumab is an approved immunotherapy that has shown an overall survival benefit in patients with cutaneous metastatic melanoma in two phase III trials. As...